Protara Therapeutics, Inc. (TARA) Financials

NASDAQ Currency in USD Disclaimer

$5.17

north_east $0.02 (0.39%)
Day's range
$5.05
Day's range
$5.2

TARA Income statement / Annual

Last year (2023), Protara Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Protara Therapeutics, Inc.'s net income was -$40.42 M. See Protara Therapeutics, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.95 M
Cost of Revenue $341,000.00 $247,000.00 $1.17 M $196,000.00 $16,000.00 $115,000.00 $148,000.00 $123,000.00 $57,000.00 $0.00
Gross Profit -$341,000.00 -$247,000.00 -$1.17 M -$196,000.00 -$16,000.00 -$115,000.00 -$148,000.00 -$123,000.00 -$57,000.00 $2.95 M
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 1
Research and Development Expenses $24.99 M $16.81 M $21.09 M $11.98 M $6.44 M $15.51 M $21.69 M $18.87 M $12.38 M $6.43 M
General & Administrative Expenses $18.62 M $20.74 M $26.40 M $22.46 M $8.82 M $10.57 M $105,989.00 $9.84 M $8.49 M $4.10 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $8.42 M -$123,000.00 -$57,000.00 $0.00
Selling, General & Administrative Expenses $18.62 M $20.74 M $26.40 M $22.46 M $8.82 M $10.57 M $8.53 M $9.71 M $8.43 M $4.10 M
Other Expenses $0.00 $29.52 M $0.00 $0.00 $0.00 $207,000.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $43.61 M $37.55 M $47.49 M $34.44 M $15.25 M $26.08 M $30.21 M $28.58 M $20.81 M $10.53 M
Cost And Expenses $43.61 M $37.55 M $47.49 M $34.44 M $15.25 M $26.08 M $30.36 M $28.71 M $20.87 M $10.53 M
Interest Income $2.73 M $1.11 M $237,000.00 $466,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $1.14 M $1.74 M $34,000.00 $0.00 $0.00 $259,000.00 $193,000.00 $144,000.00 $857,000.00
Depreciation & Amortization $341,000.00 $247,000.00 $1.17 M $196,000.00 $16,000.00 $115,000.00 $148,000.00 $123,000.00 $57,000.00 $30,000.00
EBITDA -$43.27 M -$64.57 M -$46.09 M -$33.78 M -$7.81 M -$20.61 M -$29.82 M -$28.40 M -$21.32 M -$2.45 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 -0.83
Operating Income Ratio 0 0 0 0 0 0 0 0 0 -2.57
Total Other Income/Expenses Net $3.19 M $1.11 M $237,000.00 $466,000.00 $0.00 $643,000.00 $398,000.00 $179,000.00 -$507,000.00 $4.24 M
Income Before Tax -$40.42 M -$65.95 M -$47.25 M -$33.98 M -$14.99 M -$25.44 M -$29.96 M -$28.53 M -$21.38 M -$3.34 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 -1.13
Income Tax Expense $0.00 -$1.14 M -$117,000.00 -$466,000.00 -$262,000.00 $5.35 M $657,000.00 $372,000.00 -$363,000.00 $5.10 M
Net Income -$40.42 M -$64.82 M -$47.14 M -$33.51 M -$14.73 M -$25.44 M -$29.96 M -$28.53 M -$21.38 M -$3.34 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 -1.13
EPS -3.57 -5.76 -4.2 -4.63 -228.6 -9.93 -69.38 -68.9 -51.94 -43.62
EPS Diluted -3.57 -5.76 -4.2 -4.63 -228.6 -9.93 -69.38 -68.9 -51.94 -43.62
Weighted Average Shares Out $11.33 M $11.26 M $11.23 M $7.23 M $64,437.00 $2.56 M $431,858.00 $414,044.00 $411,603.00 $76,610.00
Weighted Average Shares Out Diluted $11.33 M $11.26 M $11.23 M $7.23 M $64,437.00 $2.56 M $431,858.00 $414,044.00 $411,603.00 $76,610.00
Link